MBTPS1 and cancer: Taken together, these data strongly support the “sphingolipid rheostat” concept and indicate that modulation of S1P, ceramide, and sphingosine levels may constitute a promising anti-cancer therapy, but it also suggests that controversy still exists pertaining to the exact role of S1P in tumor progression.